Peripheral Blood Leukocyte Production of BDNF following Mitogen Stimulation in Early Onset and Regressive Autism.
Brain-derived neurotrophic factor (BDNF) is critical for neuronal differentiation and synaptic development. BDNF is also implicated in the development of psychological disorders including depression, bipolar disorder and schizophrenia. Previously, elevated BDNF levels were observed in neonatal blood samples from infants who were later diagnosed with autism when compared with children who developed normally, suggesting that BDNF may be involved in the development of autism. BDNF is produced by activated brain microglial cells, a cellular phenotype that shares several features with peripheral macrophages, suggesting an important role for the immune system in BDNF production. We hypothesized that under mitogenic stimulation, peripheral blood mononuclear cells obtained from children with autism may have altered BDNF production compared with age-matched typically developing control subjects. In addition, we examined the differences between the production of BDNF in classic/early-onset autism and children who had a regressive form of autism. We show here that plasma levels of BDNF levels are increased in children with autism, especially in early onset autism subjects. Furthermore, under mitogenic stimulation with PHA and LPS, BDNF production is significantly increased in children with autism compared with typically developing subjects. However, stimulation with tetanus toxoid results in a decreased response in children with autism. This data suggest that immune cell-derived production of BDNF could be an important source for the increased BDNF that is detected in some subjects with autism. As a neurotrophic factor produced by immune cells, BDNF could help elucidate the role of the immune system in neurodevelopment and neuronal maintenance, which may be dysregulated in autism.
Department of Medical Microbiology and Immunology and the M.I.N.D. Institute University of California at Davis.
Amanda
A
Enstrom
Department of Medical Microbiology and Immunology and the M.I.N.D. Institute University of California at Davis.
Charity
C
Onore
Department of Medical Microbiology and Immunology and the M.I.N.D. Institute University of California at Davis.
Angela
A
Tarver
Department of Public Health Sciences, Division of Epidemiology, University of California at Davis.
Irva
I
Hertz-Picciotto
Department of Pediatrics, University of California at Davis and M.I.N.D. Institute.
Robin
R
Hansen
Division of Research, Kaiser Permanente Northern California, Oakland, CA.
Lisa
L
Croen
Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis.
Judy
J
Van de Water
Department of Medical Microbiology and Immunology and the M.I.N.D. Institute University of California at Davis.
Paul
P
Ashwood
Brain-derived neurotrophic factor (BDNF); autism; inflammation; luminex; neurotrophin
J Immunol. 1999 Jun 1;162(11):6303-6
10352239
Ann Neurol. 2001 May;49(5):597-606
11357950
Brain. 2002 Jan;125(Pt 1):75-85
11834594
J Autism Dev Disord. 2000 Jun;30(3):205-23
11055457
Neurosci Lett. 2002 Aug 16;328(3):261-4
12147321
Am J Med Genet. 2001 Jan 8;105(1):36-8
11424991
Biol Psychiatry. 2006 Oct 1;60(7):690-6
16533499
Neuropsychopharmacology. 2002 Feb;26(2):204-15
11790516
J Neuropathol Exp Neurol. 1998 Jul;57(7):645-52
9690668
J Child Psychol Psychiatry. 2002 Sep;43(6):807-21
12236615
Biol Psychiatry. 2003 Jul 1;54(1):70-5
12842310
Glia. 2007 Feb;55(3):233-8
17106878
J Autism Dev Disord. 2003 Dec;33(6):607-16
14714930
Nat Genet. 2007 Mar;39(3):319-28
17322880
J Neuroimmunol. 2006 Apr;173(1-2):126-34
16494951
J Neurochem. 1998 Feb;70(2):699-707
9453564
Neuropharmacology. 1998 Dec;37(12):1553-61
9886678
J Neuroimmunol. 2001 Nov 1;120(1-2):170-9
11694332
Cell Mol Neurobiol. 2002 Feb;22(1):25-33
12064515
J Neurosci. 2003 Jan 1;23(1):297-302
12514227
J Autism Dev Disord. 1997 Oct;27(5):501-17
9403369
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16834-9
17053076
Int J Dev Neurosci. 2006 Feb;24(1):73-80
16289943
Brain Dev. 2004 Aug;26(5):292-5
15165668
Ment Retard Dev Disabil Res Rev. 2004;10(4):303-17
15666334
Biol Psychiatry. 2007 Jan 15;61(2):142-4
16893527
Pediatr Neurol. 2006 Sep;35(3):182-6
16939857
J Child Psychol Psychiatry. 2005 Jan;46(1):69-83
15660645
Neuroscience. 1999;93(4):1491-506
10501474
Neuroscience. 2006 Sep 29;142(1):49-58
16844311
J Neuroimmunol. 2003 May;138(1-2):49-55
12742653
J Neuroimmunol. 2005 Mar;160(1-2):204-9
15710474
J Psychiatr Res. 2004 May-Jun;38(3):335-45
15003440
Brain Behav Immun. 2006 Jul;20(4):378-88
16378711
J Neuroimmunol. 2005 Feb;159(1-2):106-12
15652408
Environ Health Perspect. 2006 Sep;114(9):1438-44
16966102
Biol Psychiatry. 2007 Jan 15;61(2):187-97
16697351
Neurosci Lett. 2006 Oct 30;407(3):268-73
16978777
J Leukoc Biol. 2006 Jul;80(1):1-15
16698940
Ann Neurol. 2005 Jan;57(1):67-81
15546155
Neuro Endocrinol Lett. 2005 Oct;26(5):439-46
16264412
Mol Psychiatry. 2005 Jun;10(6):563-71
15558079
Neuropsychopharmacology. 2003 Oct;28(10):1778-89
12865897
Mol Psychiatry. 2000 Nov;5(6):594-603
11126390
Psychol Med. 2000 Nov;30(6):1411-24
11097081
Autoimmunity. 2006 Feb;39(1):3-8
16455577
Environ Health Perspect. 2006 Jul;114(7):1119-25
16835068
Mol Psychiatry. 1997 May;2(3):247-50
9152989
Clin Microbiol Rev. 1993 Oct;6(4):382-427
8269393
Mol Psychiatry. 2005 Dec;10(12):1110-6
16103890
J Neurovirol. 2005 Feb;11(1):1-10
15804954
Am J Psychiatry. 2001 Jul;158(7):1058-66
11431227
Neuropsychobiology. 2002;45(1):1-6
11803234
Autism. 2004 Mar;8(1):21-37
15070545
Brain Res. 1999 Sep 4;840(1-2):125-37
10517960